Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

Biotech Firm to Test AIDS Vaccine

June 12, 2003

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Targeted Genetics Corp., an unprofitable developer of gene-therapy drugs, said it will begin human tests of an AIDS vaccine this year after seeing positive results in animal studies. The vaccine, tgAACO9, prompted an immune response in rabbits, the company said in a statement. Safety testing in humans will begin in the second half of 2003, according to the Seattle-based company. Earlier this year, Targeted Genetics reduced its work force and cut some research programs to conserve cash for developing its AIDS vaccine and cystic fibrosis and arthritis therapies.

Back to other CDC news for June 12, 2003

Previous Updates

Adapted from:
Seattle Post-Intelligencer
06.07.03; Bloomberg News

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More Research on Vaccines for HIV Prevention

Tools
 

Advertisement